This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
Solr Mobile Search
Page Title - Second Level
Publications and Digital Products
User account menu
Your browser is not supported
Switch to Chrome, Edge, Firefox or Safari
Main page content
Advisory: Digital Therapeutics for Management and Treatment in Behavioral Health
Publication ID
PEP23-06-00-001
Publication Date